1. A reply to "Immune related adverse events and response to immunotherapy: focus on corticosteroids.". (July 2020) Authors: Baldini, Editta; Tibaldi, Carmelo Journal: Lung cancer Issue: Volume 145(2020) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study. Issue 11 (27th November 2018) Authors: Tibaldi, Carmelo; Camerini, Andrea; Tiseo, Marcello; Mazzoni, Francesca; Barbieri, Fausto; Vittimberga, Isabella; Brighenti, Matteo; Boni, Luca; Baldini, Editta; Gilli, Annalisa; Honeywell, Richard; Chartoire, Myriam; Peters, Godefridus; Giovannetti, Elisa Journal: British journal of cancer Issue: Volume 119:Issue 11(2018) Page Start: 1326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program. (February 2020) Authors: Baldini, Editta; Lunghi, Alice; Cortesi, Enrico; Turci, Daniele; Signorelli, Diego; Stati, Valeria; Melotti, Barbara; Ricciuti, Biagio; Frassoldati, Antonio; Romano, Giampiero; Ceresoli, Giovanni Luca; Illiano, Alfonso; Verderame, Francesco; Fasola, Gianpiero; Ricevuto, Enrico; Marchetti, Paolo; ... Journal: Lung cancer Issue: Volume 140(2020) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients. (February 2011) Authors: Lemos, Clara; Giovannetti, Elisa; Zucali, Paolo A; Assaraf, Yehuda G; Scheffer, George L; van der Straaten, Tahar; D''Incecco, Armida; Falcone, Alfredo; Guchelaar, Henk-Jan; Danesi, Romano; Santoro, Armando; Giaccone, Giuseppe; Tibaldi, Carmelo; Peters, Godefridus J Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients. (February 2011) Authors: Lemos, Clara; Giovannetti, Elisa; Zucali, Paolo A; Assaraf, Yehuda G; Scheffer, George L; van der Straaten, Tahar; D''Incecco, Armida; Falcone, Alfredo; Guchelaar, Henk-Jan; Danesi, Romano; Santoro, Armando; Giaccone, Giuseppe; Tibaldi, Carmelo; Peters, Godefridus J Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Research Highlights: Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small-cell lung cancer. (February 2014) Authors: Tibaldi, Carmelo Journal: Pharmacogenomics Issue: Volume 15:Number 2(2014) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗